Status:
RECRUITING
A Prospective Cohort Study of Myasthenia Gravis in China
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Myasthenia Gravis
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this prospective cohort study is to investigate long-term therapeutic strategies for myasthenia gravis (MG) and identify potential biomarkers. The main questions it aims to answer are: 1....
Eligibility Criteria
Inclusion
- 1: Attended the outpatient department of neurology of PUMCH from 9/30/2022 to 9/30/2024.
- 2: Diagnosed as myasthenia gravis.
- 3: Follow-up time at PUMCH\>6 months.
- 4: The patient understood and signed the informed consent form.
Exclusion
- 1: Comorbidities with other conditions that cause skeletal muscle weakness make the clinical symptoms difficult to assess
- 2: Records related to comorbidities and medications were not available at baseline and during follow-up.
Key Trial Info
Start Date :
August 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT06006832
Start Date
August 20 2023
End Date
September 30 2026
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730